Raleigh-Durham News

Scion NeuroStim Raises $10 Million in Equity Funding

Alcove Team ยท 10/23/23

Scion NeuroStim Raises $10 Million in Equity Funding

Why It Matters:

This funding announcement is significant as it showcases investor confidence in Scion NeuroStim's mission to develop innovative and non-invasive neuromodulation medical devices for patients with central nervous system diseases and disorders.

The Details:

  • Scion NeuroStim has filed with the SEC to disclose $9,999,978 in equity funding from 13 investors.

  • The company is dedicated to improving the lives of patients through the development of easy-to-use medical devices.

  • The website highlights 21 patents and mentions pending patents in the U.S. and internationally.

  • The FDA has not granted marketing authorization for Scion NeuroStim's products, and they are currently unavailable for sale.

  • Scion NeuroStim was initially formed in 2007 and converted to a business corporation in January of last year.

  • Lanty Smith and Steven Bischoff are listed as directors in both the company and SEC filing.

  • Lesco Rogers, identified as a "director" in the SEC filing, serves as the company's Chief Medical Officer according to LinkedIn.

  • Rober Black, the company's CTO and COO, signed the SEC filing.

Conclusion:

Scion NeuroStim's recent $10 million equity funding provides a boost to its mission of developing innovative medical devices for patients with central nervous system diseases and disorders. With a focus on non-invasive neuromodulation, the company aims to make a difference in patient care.